Artrya Limited (AU:AYA) has released an update.
Artrya Limited has announced a significant expansion in the U.S. with a five-year strategic agreement with Cone Health, aiming to integrate its AI-driven Salix Coronary Anatomy software across an extensive network in North Carolina. The partnership is set to validate and refine the technology in a large-scale clinical setting, with the goal of rapid deployment post-FDA approval. This move marks Artrya’s third major U.S. agreement, showcasing its deliberate approach to capture the cardiovascular care market with the support of renowned cardiologist Dr. Wesley O’Neal.
For further insights into AU:AYA stock, check out TipRanks’ Stock Analysis page.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
